Hiroto Sakurai

Tohoku Medical and Pharmaceutical University Hospital

Papers

Total Citations

H-Index

About

Hiroto Sakurai is a leading authority in hepatobiliary and pancreatic surgery, with a focused expertise in the management of biliary tract cancer (BTC). His work addresses the critical challenges of this rare and aggressive disease, where tumor location profoundly influences both malignancy and surgical risk. Sakurai’s major contribution lies in systematically analyzing perioperative outcomes, particularly the persistently high mortality rates associated with hilar cholangiocarcinoma and gallbladder cancer. By defining benchmark cases and treatment strategies, his research provides a crucial framework for improving surgical safety and patient selection. His most-cited paper, “Current insights and future perspectives of treatment strategies for biliary tract cancer,” synthesizes the latest evidence to guide clinical decision-making. While early in its citation history, this work represents a vital resource for surgeons and oncologists navigating the complexities of BTC. Sakurai’s dedication to refining surgical protocols and reducing perioperative mortality positions him as a key voice in advancing the standard of care for patients with these challenging malignancies.